
Jyothy Labs Reports Q1 FY27 Results, Navigating Commodity Headwinds with Segment Resilience
Mumbai: Jyothy Labs Limited, a leading fast-moving consumer goods (FMCG) company in India, announced its unaudited financial results for the quarter ended June 30, 2026. The Company reported revenue of ₹773 crore for Q1 FY27, reflecting a value growth of 3.0% year-on-year. Despite facing challenges from elevated commodity inflation and volatile crude-linked input costs, the company demonstrated resilience across its core business segments.The results show that when excluding sales from Pril and Fa, revenue grew by 8.1% in value terms and 5.3% in volume terms. The operating EBITDA margin stood at 8.4%, as management focused on driving procurement efficiencies, cost mitigation through calibrated pricing actions, and supply-chain optimization to counter pressure.
Q1 FY27 Financial Highlights
The financial performance for the quarter is summarized below:| Metric | Value |
|---|---|
| Revenue | ₹ 773 crore |
| Revenue (Excl Pril and Fa) | N/A (Value Growth: 8.1%, Volume Growth: 5.3%) |
| Operating EBITDA | ₹ 64.7 crore |
| Operating EBITDA Margin | 8.4% |
| Profit After Tax | ₹ 47.6 crore |
The demand environment was noted as mixed during the quarter, with rural markets exhibiting relative resilience while urban consumption remained subdued. The company continued to focus on uninterrupted operations and maintaining strategic channels such as Modern Trade, E-commerce, and Quick Commerce, supported by a robust innovation pipeline and disciplined cost management.
Segment Performance Details
Jyothy Labs detailed strong growth in its Fabric Care segment. This segment reported 14.1% value growth and 10.2% volume growth, driven by momentum across the portfolio including liquid detergents and detergent powders.The Home Care segment recorded a 2.4% growth excluding Pril sales. The segment saw encouraging consumer response for the recently launched bio-enzyme based Exo Dishwash Liquid, endorsed by celebrities Yami Gautam and Keerthy Suresh. Furthermore, in Household Insecticides, the Company introduced Maxo Incense Sticks, a government-approved mosquito control solution designed to address concerns regarding unsafe alternatives, thus expanding the Maxo portfolio.
In Personal Care, the segment remained broadly stable. The Margo portfolio achieved modest growth, benefiting from focused brand building initiatives and improved market visibility.
Management Commentary
Ms. M. R. Jyothy, Chairperson and Managing Director of Jyothy Labs Limited, addressed the financial results for Q1 FY27. She noted that while the quarter was marked by elevated commodity inflation and volatile crude-linked input costs, the underlying business maintained resilience."Fabric Care maintained strong momentum, while Home Care delivered encouraging progress," Ms. Jyothy stated. "The launch of Maxo Incense Sticks further strengthened our innovation pipeline, supported by the positive market response to Exo Dishwash Liquid."
Ms. Jyothy added that despite persistent near-term margin pressures, the company remains cautiously optimistic about demand and growth prospects for FY27. She expressed belief in progressive improvement as cost inflation moderates, fueled by premiumisation, calibrated pricing actions, disciplined cost management, and expanding presence across emerging channels.
JYOTHYLAB Stock Price Movement
Shares of Jyothy Labs Limited slipped today by 2.83% to settle near ₹198.26, following the post-market session that saw movement from its previous close of ₹204.04. The stock traded within a range between a high of ₹203.5 and a low of ₹190.11, with 2.71 million shares changing hands during trading hours.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.